AI assistant
ETHZilla Corp — Director's Dealing 2020
Dec 2, 2020
33039_dirs_2020-12-01_c744d8f0-37d8-45e3-a255-2172eebd95fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2020-11-17
Reporting Person: KRAUSS MARLENE (10% Owner)
Reporting Person: KBL IV SPONSOR LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-25 | Common Stock | S | 12182 | $2.7753 | Disposed | 2571556 | Indirect |
| 2020-11-23 | Common Stock | S | 60633 | $3.2602 | Disposed | 2583738 | Indirect |
| 2020-11-19 | Common Stock | S | 33445 | $2.118 | Disposed | 2644371 | Indirect |
| 2020-11-18 | Common Stock | S | 6700 | $2.3105 | Disposed | 2677816 | Indirect |
| 2020-11-17 | Common Stock | S | 3300 | $2.2562 | Disposed | 2684516 | Indirect |
Footnotes
F1: The shares are held directly by KBL Sponsor. Dr. Marlene Krauss, the former Chief Executive Officer, and a former memeber of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by KBL Sponsor in which she does not have a pecuniary interest.